Case File №
#VI-2026-0650
TCI
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
41 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 7.6 | 7.6 | 7.6 | 10 Jun 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 |
| AA Water | X N/A | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 |
| AICAR | X N/A | 1 | 8.5 | 8.5 | 8.5 | 27 Feb 2025 |
| Anavar (Oxandrolone) | X N/A | 1 | 8.2 | 8.2 | 8.2 | 13 Feb 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 1 | 7.1 | 7.1 | 7.1 | 27 Feb 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 |
| Boldenone Cypionate | X N/A | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 |
| Boldenone Undecylenate (EQ) Raw | X N/A | 1 | 6.6 | 6.6 | 6.6 | 14 Jan 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 8.5 | 8.5 | 8.5 | 3 Jun 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 8.0 | 8.0 | 8.0 | 20 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 7.9 | 7.9 | 7.9 | 6 May 2025 |
| Clomid | X N/A | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| Crystagen | X N/A | 1 | 5.5 | 5.5 | 5.5 | 9 Jun 2025 |
| Epithalon | X N/A | 1 | 7.4 | 7.4 | 7.4 | 20 Jun 2025 |
| Estradiol Cypionate | X N/A | 1 | 8.8 | 8.8 | 8.8 | 7 May 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 1 | 8.6 | 8.6 | 8.6 | 13 Feb 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 7.5 | 7.5 | 7.5 | 9 Jun 2025 |
| IGF-1 LR3 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 2 Jul 2025 |
| Methylstenbolone | X N/A | 1 | 7.7 | 7.7 | 7.7 | 13 Jun 2025 |
| MGF | X N/A | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 |
| MK-677 (Ibutamoren) Raw | X N/A | 1 | 6.6 | 6.6 | 6.6 | 13 Feb 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 10.0 | 10.0 | 10.0 | 20 Jun 2025 |
| NAD+ | X N/A | 1 | 9.7 | 9.7 | 9.7 | 7 May 2025 |
| Orforglipron | X N/A | 1 | 7.3 | 7.3 | 7.3 | 9 Jun 2025 |
| P21 | X N/A | 1 | 5.3 | 5.3 | 5.3 | 24 Apr 2025 |
| PE 22-28 | X N/A | 1 | 7.5 | 7.5 | 7.5 | 24 Apr 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 8.4 | 8.4 | 8.4 | 27 Feb 2025 |
| Prostamax | X N/A | 1 | 8.3 | 8.3 | 8.3 | 3 Jun 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 9.2 | 9.2 | 9.2 | 3 Jun 2025 |
| Selank | X N/A | 1 | 5.4 | 5.4 | 5.4 | 28 Mar 2025 |
| Semax | X N/A | 1 | 9.8 | 9.8 | 9.8 | 14 Jan 2025 |
| SS-31 (Elamipretide) Raw | X N/A | 1 | 8.7 | 8.7 | 8.7 | 27 Feb 2025 |
| Supertest 450 | X N/A | 1 | 7.8 | 7.8 | 7.8 | 6 May 2025 |
| Sustanon 400 | X N/A | 1 | 8.6 | 8.6 | 8.6 | 20 Jun 2025 |
| Testagen | X N/A | 1 | 7.1 | 7.1 | 7.1 | 28 Mar 2025 |
| Testosterone Phenylpropionate Raw | X N/A | 1 | 8.8 | 8.8 | 8.8 | 27 Feb 2025 |
| Trenbolone Enanthate Raw | X N/A | 1 | 7.3 | 7.3 | 7.3 | 21 May 2025 |
| Vilon | X N/A | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 8.4 | 8.4 | 8.4 | 3 Jul 2025 |
Exhibit II
Evidence Log
41 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Selank 10mg + Semax 10mg Blend | 8.7 A | 50mg | 43.0mg | -14.0% | 99.37% | jqjpus | Lab B | Community |
| 25 May 2026 | Vitamin B12 1mg/ml | 7.7 A | 200mg/ml | 233.3mg/ml | +16.7% | 97.14% | qjnyze | Lab A | Public |
| 24 May 2026 | Boldenone Cypionate | 5.7 B | 300mg/ml | 278.5mg/ml | -7.2% | 95.11% | hkxwz3 | Lab E | Public |
| 24 May 2026 | Crystagen | 5.8 B | 20mg | 23.4mg | +16.8% | 95.02% | 1xe2to | Lab E | Public |
| 24 May 2026 | IGF-1 LR3 | 9.3 A | 10mg | 9.9mg | -0.8% | 98.61% | a8i3vx | Lab E | Public |
| 24 May 2026 | Prostamax | 7.7 A | 10mg | 10.6mg | +6.1% | 96.26% | 12qwxg | Lab E | Community |
| 24 May 2026 | Sustanon 400 | 10.0 A | 300mg/ml | 290.3mg/ml | -3.2% | 97.10% | a9yult | Lab A | Community |
| 24 May 2026 | Testagen | 4.6 C | 5mg | 4.7mg | -6.3% | 95.46% | v46dpk | Lab A | Public |
| 24 May 2026 | MGF | 6.1 A | 2mg | 2.3mg | +15.4% | 99.14% | rvnx4c | Lab E | Public |
| 23 May 2026 | AICAR | 10.0 A | 50mg | 62.5mg | +25.0% | 95.04% | 1isj2c | Lab B | Public |
| 23 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.7 A | 30mg | 37.2mg | +24.0% | 95.64% | oag69e | Lab D | Community |
| 21 May 2026 | Semax | 9.9 A | 2mg | 2.5mg | +23.8% | 96.30% | vilm49 | Lab G | Public |
| 19 May 2026 | Boldenone Undecylenate (EQ) Raw | 4.8 C | 500g | 613.9g | +22.8% | 99.87% | 65l9c1 | Lab G | Public |
| 17 May 2026 | Testosterone Phenylpropionate Raw | 7.4 A | 1g | 1.2g | +15.9% | 97.45% | gnfgam | Lab G | Community |
| 17 May 2026 | Trenbolone Enanthate Raw | 7.8 A | 5g | 6.1g | +21.1% | 98.59% | axyaxe | Lab C | Public |
| 26 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 9.0 A | 5mg | 4.4mg | -11.4% | 95.25% | mv697d | Lab E | Community |
| 26 Jan 2026 | MK-677 (Ibutamoren) Raw | 7.4 A | 100g | 102.3g | +2.3% | 99.86% | bogwnc | Lab C | Public |
| 19 Jan 2026 | Clomid | 8.3 A | 20mg | 20.9mg | +4.4% | 95.40% | tpp720 | Lab D | Public |
| 9 Jan 2026 | SS-31 (Elamipretide) Raw | 8.1 A | 100g | 87.3g | -12.7% | 95.29% | 7k79jp | Lab F | Community |
| 7 Jan 2026 | Anavar (Oxandrolone) | 7.6 A | 10mg | 11.3mg | +13.0% | 99.86% | fe0hyo | Lab C | Community |
| 7 Jan 2026 | Estradiol Cypionate | 7.7 A | 100mg/ml | 99.0mg/ml | -1.0% | 95.42% | ouhk0y | Lab C | Public |
| 7 Jan 2026 | Vilon | 9.7 A | 2mg | 1.9mg | -6.1% | 96.19% | 73i9gw | Lab G | Public |
| 6 Jan 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 6.4 A | 5g | 6.2g | +24.0% | 98.32% | 4p3o50 | Lab G | Public |
| 6 Jan 2026 | Epithalon | 6.6 A | 50mg | 56.2mg | +12.4% | 95.82% | s4rhgy | Lab D | Community |
| 29 Dec 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.6 A | 250mg/ml | 293.6mg/ml | +17.5% | 98.29% | w8s65m | Lab G | Public |
| 29 Dec 2025 | BMK methyl glycidate CAS 80532-66-7 | 5.5 B | 100g | 100.4g | +0.4% | 99.15% | gnsm9q | Lab B | Community |
| 29 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 8.8 A | 50mg | 52.0mg | +4.1% | 96.58% | xxl2d2 | Lab G | Public |
| 29 Dec 2025 | PE 22-28 | 9.0 A | 20mg | 23.2mg | +15.8% | 99.51% | frkhi6 | Lab A | Public |
| 29 Dec 2025 | Supertest 450 | 7.2 A | 300mg/ml | 367.2mg/ml | +22.4% | 96.01% | j9j5yg | Lab A | Community |
| 12 Dec 2025 | Methylstenbolone | 7.2 A | 25mg | 28.5mg | +14.0% | 95.35% | o8ze58 | Lab G | Public |
| 23 Nov 2025 | P21 | 4.5 C | 5mg | 5.8mg | +16.0% | 97.97% | mob4yz | Lab F | Community |
| 23 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 9.1 A | 100mg | 97.4mg | -2.6% | 98.39% | wp9wyg | Lab G | Public |
| 23 Nov 2025 | Selank | 4.1 C | 10mg | 9.7mg | -3.0% | 98.54% | kjr28y | Lab C | Community |
| 17 Nov 2025 | Cerebrolysin | 8.4 A | 15mg | 14.0mg | -6.9% | 95.36% | w6mnua | Lab A | Community |
| 14 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 8.1 A | 30mg | 32.5mg | +8.3% | 95.15% | e6yjcd | Lab A | Public |
| 14 Nov 2025 | NAD+ | 9.8 A | 50mg | 43.0mg | -14.0% | 96.38% | fuzpvs | Lab A | Public |
| 14 Nov 2025 | Orforglipron | 8.1 A | 50mg | 51.7mg | +3.4% | 96.91% | 0zufn3 | Lab G | Public |
| 17 Oct 2025 | N-Acetyl Epitalon Amidate | 8.8 A | 30mg | 36.7mg | +22.5% | 97.18% | kui2bq | Lab E | Public |
| 17 Oct 2025 | Retatrutide 30mg Pen Kit | 5.0 B | 50mg | 51.8mg | +3.5% | 97.62% | r9wyus | Lab F | Community |
| 9 Oct 2025 | AA Water | 5.8 B | 10mg | 10.5mg | +5.0% | 99.69% | xthrxn | Lab G | Community |
| 10 Jun 2025 | Retatrutide | 7.6 A | 10mg | 9.92mg | -0.8% | 99.75% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —